Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


HDSS Profile: Mlomp Health and Demographic Surveillance System (Mlomp HDSS), Senegal.

Pison G, Beck B, Ndiaye O, Diouf PN, Senghor P, Duthé G, Fleury L, Sokhna C, Delaunay V.

Int J Epidemiol. 2018 Aug 1;47(4):1025-1033. doi: 10.1093/ije/dyy075. No abstract available.


Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors.

Rondelet G, Fleury L, Faux C, Masson V, Dubois J, Arimondo PB, Willems L, Wouters J.

Future Med Chem. 2017 Sep;9(13):1465-1481. doi: 10.4155/fmc-2017-0074. Epub 2017 Aug 10.


Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells.

Halby L, Menon Y, Rilova E, Pechalrieu D, Masson V, Faux C, Bouhlel MA, David-Cordonnier MH, Novosad N, Aussagues Y, Samson A, Lacroix L, Ausseil F, Fleury L, Guianvarc'h D, Ferroud C, Arimondo PB.

J Med Chem. 2017 Jun 8;60(11):4665-4679. doi: 10.1021/acs.jmedchem.7b00176. Epub 2017 May 23.


Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells.

Gregoire JM, Fleury L, Salazar-Cardozo C, Alby F, Masson V, Arimondo PB, Ausseil F.

BMC Cancer. 2016 Aug 31;16:700. doi: 10.1186/s12885-016-2683-5.


Asymmetric Synthesis and Binding Study of New Long-Chain HPA-12 Analogues as Potent Ligands of the Ceramide Transfer Protein CERT.

Ďuriš A, Daïch A, Santos C, Fleury L, Ausseil F, Rodriguez F, Ballereau S, Génisson Y, Berkeš D.

Chemistry. 2016 May 4;22(19):6676-86. doi: 10.1002/chem.201505121. Epub 2016 Mar 31.


The CERT antagonist HPA-12: first practical synthesis and individual binding evaluation of the four stereoisomers.

Santos C, Fleury L, Rodriguez F, Markus J, Berkeš D, Daïch A, Ausseil F, Baudoin-Dehoux C, Ballereau S, Génisson Y.

Bioorg Med Chem. 2015 May 1;23(9):2004-9. doi: 10.1016/j.bmc.2015.03.019. Epub 2015 Mar 12.


Development of a CERT START Domain-Ceramide HTRF Binding Assay and Application to Pharmacological Studies and Screening.

Fleury L, Faux C, Santos C, Ballereau S, Génisson Y, Ausseil F.

J Biomol Screen. 2015 Jul;20(6):779-87. doi: 10.1177/1087057115573402. Epub 2015 Feb 23.


New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.

Gros C, Fleury L, Nahoum V, Faux C, Valente S, Labella D, Cantagrel F, Rilova E, Bouhlel MA, David-Cordonnier MH, Dufau I, Ausseil F, Mai A, Mourey L, Lacroix L, Arimondo PB.

J Biol Chem. 2015 Mar 6;290(10):6293-302. doi: 10.1074/jbc.M114.594671. Epub 2014 Dec 18.


TIP48/Reptin and H2A.Z requirement for initiating chromatin remodeling in estrogen-activated transcription.

Dalvai M, Fleury L, Bellucci L, Kocanova S, Bystricky K.

PLoS Genet. 2013 Apr;9(4):e1003387. doi: 10.1371/journal.pgen.1003387. Epub 2013 Apr 18.


Interallelic class switch recombination contributes significantly to class switching in mouse B cells.

Reynaud S, Delpy L, Fleury L, Dougier HL, Sirac C, Cogné M.

J Immunol. 2005 May 15;174(10):6176-83.

Supplemental Content

Loading ...
Support Center